Page last updated: 2024-09-05

hmr 1766 and Cardiovascular Diseases

hmr 1766 has been researched along with Cardiovascular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Schmidt, HH; Schmidt, PM; Stasch, JP	1

Reviews

1 review(s) available for hmr 1766 and Cardiovascular Diseases

Article	Year
NO- and haem-independent soluble guanylate cyclase activators. Handbook of experimental pharmacology, 2009, Issue:191 Topics: Animals; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Drug Delivery Systems; Enzyme Activators; Guanylate Cyclase; Heme; Humans; Nitric Oxide; ortho-Aminobenzoates; Oxidative Stress; Receptors, Cytoplasmic and Nuclear; Risk Factors; Soluble Guanylyl Cyclase; Sulfonamides	2009

Article

Year

NO- and haem-independent soluble guanylate cyclase activators.

Handbook of experimental pharmacology, 2009, Issue:191

Topics: Animals; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Drug Delivery Systems; Enzyme Activators; Guanylate Cyclase; Heme; Humans; Nitric Oxide; ortho-Aminobenzoates; Oxidative Stress; Receptors, Cytoplasmic and Nuclear; Risk Factors; Soluble Guanylyl Cyclase; Sulfonamides

2009